openPR Logo
Press release

Biomarkers Market - North America to Dominate the Market by 2021

03-28-2017 04:20 PM CET | Health & Medicine

Press release from: Market Research Engine Report - MRE

New York, March 28: Market Research Engine has published a new report titled as “Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023”

The Biomarkers market is expected to exceed more than US$ 50.0 billion by 2021 growing at around 13% CAGR.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/biomarkers-market

Biomarkers are biological measures used to measure biological states such as blood pressure, cholesterol level and monitor and forecast health level of individual. Biomarkers are used in single or in combination to identify health or disease of individual. Different varieties of biomarkers are used currently for various applications. Every biological system consists of its own biomarkers. Some biomarkers are easy to use, measure and form part of routine medical examinations. Biomarkers are used to estimate health and disease of individual such as diabetes and cardiovascular. Biomarkers are used for detection, screening, diagnosis, treatment and monitoring of cancer.

The Biomarkers market is expected to exceed more than US$ 50.0 billion by 2021 growing at around 13% CAGR. The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing cost of biomarkers is high. It contains high investment but relatively low cost and benefit ratio.

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/biomarkers-market

This report provides:

1) An overview of the global market for biomarkers and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

3) Identifications of new market opportunities and targeted promotional plans for biomarkers.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for various types of biomarkers with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories , Enzo Biochem , EKF Diagnostics Holdings plc , Meso Scale Diagnostics, LLC , Singulex, Inc. , BioSims Technologies , Cisbio Bioassays , and Signosis, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Biomarkers Market has been segmented as below:

By Product Segment Analysis

• Consumable
• Services
• Software

By Type Analysis

• Safety biomarker,
• Efficacy biomarker
• Validation biomarker

By Application Analysis

• Diagnostics development
• Drug discovery & development
• Personalized medicine
• Disease risk assessment

By Disease Indication Analysis

• Cancer
• Cardiovascular disorders
• Neurological disorders
• Immunological disorders

By Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarkers Market - North America to Dominate the Market by 2021 here

News-ID: 484394 • Views:

More Releases from Market Research Engine Report - MRE

Nonwoven filter media Market 2019 Outlook, Opportunity and Demand Analysis Repor …
New York, June 15, 2019: The Global Nonwoven Filter Media Market is expected the highest growth during the projected period. Manufacturers widely use this filtration media in air, gas and liquid filtration processes. Growing consumer awareness regarding health issues vis-à-vis product safety, air quality, water purity etc. drives the market. However, an unfavourable regulatory environment, especially concerning applications that involve the use of nonwoven filter media is restricting market growth.
Nuclear Medicine/Radiopharmaceuticals Market is Expected to Exceed US$ 4.5 Billi …
The important factors driving the nuclear medicine market are advances in radiotracers and alpha radio immunotherapy-based targeted cancer treatment. SPECT and PET scans usage has been increasing to detect diseases like cancer which is driving the nuclear medicine market. Raising the incidence of cancer and cardiac ailments are also responsible for growing the nuclear medicine market. The nuclear medicine market is also having some restraints such as strict regulatory and
Antidiabetics Market is Expected to Reach USD 80.0 Billion by 2022
The global antidiabetics market is segmented based on its product which includes thiazolodinediones, glp-agonists, sulphonylureas, dpp-4 inhibitors, sglt-2, alpha-glucosidase inhibitors, biguanides and meglitinides. The insulin is segmented as rapid acting, long acting, premixed, premixed analog, short acting and intermediate acting. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW). Browse Full Report @: https://www.marketresearchengine.com/reportdetails/antidiabetics-market How Big is the Global Antidiabetics Market? Global Antidiabetics
Curcumin Market is Expected to Exceed USD 100 Million by 2022
The global curcumin market is segmented based on its applications which include food, cosmetics, pharmaceuticals and others. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW). Browse Full Report @: https://www.marketresearchengine.com/reportdetails/curcumin-market How Big is the Global Curcumin Market? Global Curcumin market is anticipated to reach USD 95 million by 2021, Pharmaceutical was leading application segment in global curcumin market accounting over 45% of

All 5 Releases


More Releases for Biomarkers

Predisposition Biomarkers Market - Rapid Growth at Deep Value Price from 2020-20 …
"The new report has been added by qyresearch.com to provide detailed insight into the global Predisposition Biomarkers market. The study will help to get a better understanding about the Predisposition Biomarkers industry competitors, a channel for the distribution, Predisposition Biomarkers growth potential, potentially disruptive trends, Predisposition Biomarkers industry product innovations, market size value/volume (regional/country level, Predisposition Biomarkers industry segments), market share of top players/products. Due to the pandemic, we have included
3rd World Biomarkers Summit
We cordially invite you to the 3rd World Biomarkers Summit to be held at Rome, Italy on April 22-23, 2020. The 2020 edition of the Biomarkers conference will move forward with the theme “Biomarker as a future protagonist”. Biomarkers 2020 concentrates on procuring emerging researches in the sector of medicine and health brought to us via applications of biomarkers. Scientists, Young researchers, pharmaceutical industrialists and medical professionals are expected to
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out